•  
  •  
  •  
  •  

2025-10-06 16:36:20

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • HCLTech joins MIT Media Lab in the US to collaborate on next-gen AI research
  • TVS Motor Company launches most advanced TVS Raider variant
  • Zydus receives final approval from USFDA for Deflazacort oral suspension, 22.75 mg/mL
  • Deepak Group Unveils State-of-the-Art Next-Generation R&D Centre to Pioneer Innovations in Chemistry
  • Smt. Bhuvaneswari Nara selected for IOD's Distinguished Fellowship - 2025

Keywords Selected:  CID

Stock Report

  • Bhageria Industries Limited to expand H-ACID capacity
  • Shilpa Medicare announces the approval of Nor Ursodeoxycholic Acid Tablets 500 mg for the treatment of Non‐Alcoholic Fatty Liver Disease in India
  • India levies anti-dumping duty on imports of Trichloro Isocyanuric Acid from China PR and Japan
  • UP CM Shri Yogi Adityanath ji Lays Foundation for India's First PLA Biopolymer Plant by Balrampur Chini Mills Limited
  • Shilpa Medicare announces successful outcome of Phase 3 studies of SMLNUD07 - NorUDCA
  • Shilpa Pharma Lifesciences Ltd received CEP from EDQM for API, Ursodeoxycholic Acid
  • Infosys Foundation Commits over INR 33 Crore Towards Strengthening Karnataka Police's Cybercrime Investigation Capabilities
  • Balrampur Chini Mills Ltd is set to venture into Poly Lactic Acid manufacturing with a new fully integrated facility
  • Strides launches Icosapent Ethyl Acid Soft Gel Capsules in partnership with Amneal
  • A-1 Acid Ltd posts consolidated loss of Rs. 4 lakhs in Q2 FY24
  • Gujarat Alkalies and Chemicals Ltd commences commercial production of Purified Phosphoric Acid
  • TANFAC Industries Ltd gets TNPCB consent for expansion of Hydrofluoric Acid Plant at Cuddalore
  • A-1 Acid Ltd consolidated Q4 FY2022-23 net profit up QoQ to Rs. 1.13 crore
  • Navin Fluorine Advanced Sciences Ltd approves capex of Rs. 450 crores
  • A-1 Acid Ltd reports consolidated Q3 FY23 PAT of Rs. 18.81 lakhs
  • Zydus receives final approval from the USFDA for Famotidine Injection
  • Aarti Industries and Deepak Fertilisers sign long term binding term-sheet for Nitric Acid offtake
  • A-1 Acid Ltd Q2FY23 net profit at Rs. 7.75 lakhs
  • A-1 Acid Ltd updates on advance tax payment
  • A-1 Acid Ltd posts Q1 FY2023 consolidated profit of Rs. 2.26 crore
  • Zydus Lifesciences receives final approval from USFDA for Famotidine Tablets
  • Aksharchem India Ltd to stop production of H-Acid plant
  • Sun Pharma to launch Brillo®, a first-in-class oral lipid-lowering drug in India
  • Kimia Biosciences Ltd gets permission for Bemopedoic acid bulk drug

Latest Post

  • HCLTech joins MIT Media Lab in the US to collaborate on next-gen AI research
  • TVS Motor Company launches most advanced TVS Raider variant
  • Zydus receives final approval from USFDA for Deflazacort oral suspension, 22.75 mg/mL
  • Deepak Group Unveils State-of-the-Art Next-Generation R&D Centre to Pioneer Innovations in Chemistry
  • Smt. Bhuvaneswari Nara selected for IOD's Distinguished Fellowship - 2025


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024